Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124806702 | 12480670 | 2 | F | 2006 | 20160707 | 20160620 | 20160711 | EXP | US-GLAXOSMITHKLINE-US2016GSK086310 | GLAXOSMITHKLINE | 0.00 | F | Y | 66.68000 | KG | 20160711 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124806702 | 12480670 | 1 | PS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Y | 18644 | |||||||||||
| 124806702 | 12480670 | 2 | SS | BUPROPION. | BUPROPION | 1 | Y | 18644 | |||||||||||
| 124806702 | 12480670 | 3 | SS | XANAX | ALPRAZOLAM | 1 | Y | 0 | |||||||||||
| 124806702 | 12480670 | 4 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Y | 0 | |||||||||||
| 124806702 | 12480670 | 5 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Y | 0 | |||||||||||
| 124806702 | 12480670 | 6 | SS | SERTRALINE HYDROCHLORIDE. | SERTRALINE HYDROCHLORIDE | 1 | Y | 0 | |||||||||||
| 124806702 | 12480670 | 7 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 150 MG, UNK | Y | 0 | 150 | MG | ||||||||
| 124806702 | 12480670 | 8 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | 150 MG, UNK | Y | 0 | 150 | MG | ||||||||
| 124806702 | 12480670 | 9 | SS | PREMARIN | ESTROGENS, CONJUGATED | 1 | 1.25 MG, UNK | 0 | 1.25 | MG | |||||||||
| 124806702 | 12480670 | 10 | SS | TOVIAZ | FESOTERODINE FUMARATE | 1 | 4 MG, QD | 0 | 4 | MG | QD | ||||||||
| 124806702 | 12480670 | 11 | SS | AMBIEN | ZOLPIDEM TARTRATE | 1 | 5 MG, UNK | Y | 0 | 5 | MG | ||||||||
| 124806702 | 12480670 | 12 | SS | AMBIEN | ZOLPIDEM TARTRATE | 1 | 10 MG, UNK | Y | 0 | 10 | MG | ||||||||
| 124806702 | 12480670 | 13 | SS | ATIVAN | LORAZEPAM | 1 | 1 MG, UNK | Y | 0 | 1 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124806702 | 12480670 | 1 | Depression |
| 124806702 | 12480670 | 2 | Depression |
| 124806702 | 12480670 | 3 | Product used for unknown indication |
| 124806702 | 12480670 | 4 | Product used for unknown indication |
| 124806702 | 12480670 | 5 | Product used for unknown indication |
| 124806702 | 12480670 | 6 | Product used for unknown indication |
| 124806702 | 12480670 | 7 | Depression |
| 124806702 | 12480670 | 8 | Depression |
| 124806702 | 12480670 | 9 | Hyperhidrosis |
| 124806702 | 12480670 | 10 | Bladder disorder |
| 124806702 | 12480670 | 11 | Product used for unknown indication |
| 124806702 | 12480670 | 13 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124806702 | 12480670 | HO |
| 124806702 | 12480670 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124806702 | 12480670 | Anxiety | |
| 124806702 | 12480670 | Decreased appetite | |
| 124806702 | 12480670 | Depressed mood | |
| 124806702 | 12480670 | Dysgeusia | |
| 124806702 | 12480670 | Emotional distress | |
| 124806702 | 12480670 | Lethargy | |
| 124806702 | 12480670 | Restlessness | |
| 124806702 | 12480670 | Sexual dysfunction | |
| 124806702 | 12480670 | Suicidal ideation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |